Liege, Belgium, 2 June 2022 – 7:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the “Company” or “Mithra”), a company dedicated to Women’s Health, today announces that Goldman Sachs International (“GSI”) has elected to exercise the last call option in relation to the outstanding drawdown of EUR 5 million, and provides additional information on its financing strategy.